Industry News
The latest pharmaceutical and supplement industry news — regulation updates, safety alerts, market trends, and research breakthroughs.
Eli Lilly Stock Surges 7% to Record High on Market Momentum
Eli Lilly shares jumped 7% to reach record highs, reflecting strong investor confidence in the pharmaceutical giant's portfolio and financial trajectory.
Pharma Industry Embraces API-Based Drug Databases for Multi-Market Compliance
Swiss and EU pharmaceutical companies are adopting validated API-based drug databases to streamline regulatory compliance across CH, EU, and US markets, reducing costs and approval times.
UAE's First AI-Discovered Drug Enters Trials, Signals Global Shift
The UAE's first fully AI-designed drug candidate reaches clinical development with 80-90% Phase 1 success rates, marking a geographic expansion of AI pharma innovation.
Trump Signs Spending Bill with New PBM Oversight Rules
New federal regulations targeting pharmacy benefit managers aim to increase transparency in drug pricing as industry stakeholders debate responsibility for rising costs.
Medicare Launches GLP-1 Bridge Program for Obesity Treatment Access
Novo Nordisk's Medicare GLP-1 Bridge program expands access to FDA-approved weight-loss medications, potentially reshaping the $151.9B obesity treatment market.
Moringa Salmonella Crisis Expands to Multiple Manufacturers Nationwide
CDC investigation widens as salmonella contamination in moringa supplements spreads beyond initial recall, affecting multiple brands and signaling supply chain crisis.
OpenAI Debuts GPT-Rosalind: AI Model Built for Drug Discovery
OpenAI enters pharmaceutical R&D with GPT-Rosalind, a specialized reasoning model designed for drug discovery, genomics analysis, and protein research applications.
AI Model Transforms Early Drug Interaction Safety Screening
New fusion-driven graph representation system enables pharmaceutical companies to predict drug-drug interactions for novel compounds earlier in development, potentially reducing costly failures.
HHS Unveils Major Clinical Trial Reforms in Strategic Biotech Push
U.S. health officials announce cross-agency initiative to accelerate drug approval timelines and strengthen competitive position against China's growing biotech sector.
Total Nutrition Inc. Expands Moringa Recall Amid Salmonella Concerns
Total Nutrition Inc. widens voluntary recall of moringa supplements across Amazon, Walmart, Target, and TikTok Shop due to Salmonella contamination, affecting TNVitamins and Doctor's Pride products.
FDA Issues Warning Letters to 11 Supplement Companies in Regulatory Sweep
FDA's enforcement action against 11 dietary supplement distributors signals intensified regulatory scrutiny. Learn what violations triggered the warnings and compliance expectations.
Pharma M&A Surpasses $100B in 2026 Amid Pipeline Pressures
Pharmaceutical M&A activity exceeds $100 billion in 2026, led by AbbVie's $63B Apogee deal. Industry faces mounting pressure to replenish drug pipelines.
Two-Thirds of Protein Powders Test Positive for Dangerous Lead Levels
Independent testing reveals widespread heavy metal contamination in protein supplements, with plant-based products showing highest lead concentrations across major brands.
STADA Expands VMS Portfolio with 16-Brand Acquisition from Orifarm
STADA Group strengthens consumer health division through major Nordic supplement brand acquisition, highlighting pharmaceutical industry's growing focus on VMS market growth.
FDA Cites Animal Health Firm for Serious Manufacturing Violations
FDA issues warning letter to Imu-Tek Animal Health following October 2025 inspection revealing serious CGMP violations that could compromise veterinary pharmaceutical quality.
Novo Nordisk Recalls Ozempic Pens Over Dosing Defect Concerns
Novo Nordisk initiates global recall of Ozempic injection pens due to potential dosing mechanism defects, raising quality control questions amid surging GLP-1 demand.
Lilly Launches Triple Acquisition to Expand Infectious Disease Focus
Eli Lilly acquires Curevo, LimmaTech Biologics, and Vaccine Company in simultaneous deals, marking a major strategic shift toward infectious disease R&D and vaccine development.
FDA Unveils Framework for Evidence-Based Supplement Safety Guidance
FDA is developing a comprehensive framework to help consumers evaluate dietary supplement safety and efficacy, marking a major shift toward evidence-based education in the $50B market.
Sanofi Wins EU Approval for Multiple Sclerosis Treatment
Sanofi secures European regulatory clearance for new MS therapy, expanding treatment landscape in competitive neurology market with implications for care protocols.
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion
AbbVie strengthens immunology portfolio with major acquisition of Apogee Therapeutics, signaling strategic response to patent pressures and continued consolidation.